Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a phase 1 study to assess and compare molar potency of HM12470 and regular human insulin in healthy subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Part 1 | Experimental | Intravenous (IV) infusion of HM12470 |
|
| Part 2: Sequence 1 | Experimental | Intravenous (IV) infusion of HM12470 |
|
| Part 2: Sequence 2 | Experimental | Intravenous (IV) infusion of HM12470 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| HM12470 | Biological | HM12470 is a long-acting insulin analogue |
|
| Measure | Description | Time Frame |
|---|---|---|
| Blood glucose assessment of HM12470 and regular human insulin (RHI) over the entire dosing period | - Comparison of HM12470 to RHI based on blood glucose profile generated by intravenous infusion | 1 month |
| Measure | Description | Time Frame |
|---|---|---|
| Cmax of HM12470 | - Maximum concentration of HM12470 over the entire dosing period | 1 month |
| AUC of HM12470 | - Area Under the Curve of HM12470 over the entire dosing period |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hanmi Investigative Site | Chula Vista | California | 91911 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 month |